US-based virtual care clinic Midi Health has entered into a partnership with Keck Medicine of USC to enhance access to specialised midlife care for women in the Los Angeles region.
This collaboration aims to address the unmet healthcare needs of millions of American women experiencing perimenopause and menopause symptoms.
The joint initiative will offer tailored care plans, leveraging protocols developed by experts in the field.
Midi Health's patients will receive customised care plans based on their individual symptoms and health histories, with the added convenience of all services being covered by insurance and accessible via telehealth consultations.
Hormonal changes during the menopause transition can lead to significant life disruptions for countless women, yet 75% of those who seek medical assistance fail to receive adequate advice and treatment.
Keck Medicine of USC and Midi Health noted that they will reduce this number by providing top-tier care to the women of Los Angeles dealing with such issues.
The partnership ensures that Midi's virtual clinic patients maintain a strong connection to the care and expertise of their Keck Medicine-affiliated physicians.
USC Care and Keck Medicine of USC ambulatory services CEO Smitha Ravipudi said: “We know there is a great need for expanded access to specialised perimenopause and menopause care for women, and we look forward to working with Midi Health to deliver customised care plans that address women's unique health needs at this stage of life.”
Midi Health CEO and co-founder Joanna Strober said: “We are excited to collaborate with Keck Medicine of USC as we work to address the unmet needs of millions of women who experience symptoms of menopause.
“This programme gives women access to the care they deserve, at a crucial stage in their lives.”
In April this year, Midi Health secured $60m in a Series B funding round to facilitate its efforts to improve women’s healthcare.
Emerson Collective spearheaded the funding round, which included contributions from Google Ventures.
The investment took the company’s total funding to $100m since its founding in 2021.
